Cardiovascular Biomarkers May Enhance Risk Stratification in Primary Prevention, but Evidence for Routine Clinical Use Remains Limited
Key Recommendations: 2026 ESC Guidelines for the Management of Cardiovascular Disease and Chronic Kidney Disease
Points de vue d'experts : Comment choisir entre une monothérapie, une bithérapie ou une thérapie combinée ?
World Hepatitis Day: Why Hepatitis B Remains a Global Health Challenge Despite Preventive & Treatment Advances
